Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2230)
All Articles published online
|
Publishing Process of This Article
|
Apr 16, 2023 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qi JP, Jiang H, Wu T, Zhang Y, Huang W, Li YX, Wang J, Zhang J, Ying ZH. Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report. World J Clin Cases 2023; 11(11): 2474-2481 [PMID: 37123310 DOI: 10.12998/wjcc.v11.i11.2474] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i11/2474.htm |
| Number | Citing Articles |
| 1 |
Larissa C da Rosa, Hannah E Scales, Robert A Benson, James M Brewer, Iain B McInnes, Paul Garside. The effect of abatacept on T-cell activation is not long-lived in vivo
. Discovery Immunology 2024; 3(1) doi: 10.1093/discim/kyad029
|